149 related articles for article (PubMed ID: 38185557)
21. Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T
Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
Evrard C; Messina S; Sefrioui D; Frouin É; Auriault ML; Chautard R; Zaanan A; Jaffrelot M; De La Fouchardière C; Aparicio T; Coriat R; Godet J; Silvain C; Randrian V; Sabourin JC; Guimbaud R; Miquelestorena-Standley E; Lecomte T; Moulin V; Karayan-Tapon L; Tachon G; Tougeron D
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457245
[TBL] [Abstract][Full Text] [Related]
23. Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects.
Ashktorab H; Brim H; Al-Riyami M; Date A; Al-Mawaly K; Kashoub M; Al-Mjeni R; Smoot DT; Al-Moundhri M; Al-Hashemi S; Ganguly SS; Raeburn S
Dig Dis Sci; 2008 Oct; 53(10):2723-31. PubMed ID: 18299982
[TBL] [Abstract][Full Text] [Related]
24. Simple IHC reveals complex MMR alternations than PCR assays: Validation by LCM and next-generation sequencing.
Amemiya K; Hirotsu Y; Nagakubo Y; Watanabe S; Amemiya S; Mochizuki H; Oyama T; Kondo T; Omata M
Cancer Med; 2022 Dec; 11(23):4479-4490. PubMed ID: 35596629
[TBL] [Abstract][Full Text] [Related]
25. Novel Biocartis Idylla™ cartridge-based assay for detection of microsatellite instability in colorectal cancer tissues.
Mindiola-RomeroMD AE; GreenBS DC; Al-TurkmaniPhD MR; GodwinBS KN; MackayBS AC; TafeMD LJ; RenMD B; TsongalisPhD GJ
Exp Mol Pathol; 2020 Oct; 116():104519. PubMed ID: 32822722
[TBL] [Abstract][Full Text] [Related]
26. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
27. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.
McCarthy AJ; Capo-Chichi JM; Spence T; Grenier S; Stockley T; Kamel-Reid S; Serra S; Sabatini P; Chetty R
J Pathol Clin Res; 2019 Apr; 5(2):115-129. PubMed ID: 30387329
[TBL] [Abstract][Full Text] [Related]
28. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
[TBL] [Abstract][Full Text] [Related]
29. A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer.
Kim JH; Kim SY; Baek JY; Cha YJ; Ahn JB; Kim HS; Lee KW; Kim JW; Kim TY; Chang WJ; Park JO; Kim J; Kim JE; Hong YS; Kim YH; Kim TW
Cancer Res Treat; 2020 Oct; 52(4):1135-1144. PubMed ID: 32340084
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry.
Zito Marino F; Amato M; Ronchi A; Panarese I; Ferraraccio F; De Vita F; Tirino G; Martinelli E; Troiani T; Facchini G; Pirozzi F; Perrotta M; Incoronato P; Addeo R; Selvaggi F; Lucido FS; Caraglia M; Savarese G; Sirica R; Casillo M; Lieto E; Auricchio A; Cardella F; Docimo L; Galizia G; Franco R
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565332
[TBL] [Abstract][Full Text] [Related]
31. Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods.
Yang RK; Chen H; Roy-Chowdhuri S; Rashid A; Alvarez H; Routbort M; Patel KP; Luthra R; Medeiros LJ; Toruner GA
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230473
[TBL] [Abstract][Full Text] [Related]
32. MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice.
Parente P; Malapelle U; Angerilli V; Balistreri M; Lonardi S; Pucciarelli S; De Luca C; Pepe F; Russo G; Vigliar E; Danza A; Scaramuzzi F; Troncone G; Graziano P; Fassan M
J Clin Pathol; 2023 Jul; 76(7):492-496. PubMed ID: 35145019
[TBL] [Abstract][Full Text] [Related]
33. A comparison of performance of 6-mononucleotide site panel and NCI panel for microsatellite instability detection in patients with colorectal adenocarcinoma.
He L; Yang J; Zhang B; Wang Y; Wang J; Ye Q
Pathol Res Pract; 2023 Apr; 244():154390. PubMed ID: 36905693
[TBL] [Abstract][Full Text] [Related]
34. Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study.
Malapelle U; Parente P; Pepe F; De Luca C; Cerino P; Covelli C; Balestrieri M; Russo G; Bonfitto A; Pisapia P; Fiordelisi F; D'Armiento M; Bruzzese D; Loupakis F; Pietrantonio F; Triassi M; Fassan M; Troncone G; Graziano P
Cells; 2020 Sep; 9(9):. PubMed ID: 32887373
[TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer.
Lee CT; Chow NH; Chen YL; Ho CL; Yeh YM; Lin SC; Lin PC; Lin BW; Chu CA; Tsai HW; Lee JC
Pathol Res Pract; 2021 Jan; 217():153288. PubMed ID: 33276219
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite instability in mismatch repair proficient colorectal cancer: clinical features and underlying molecular mechanisms.
Xu Y; Liu K; Li C; Li M; Zhou X; Sun M; Zhang L; Wang S; Liu F; Xu Y
EBioMedicine; 2024 May; 103():105142. PubMed ID: 38691939
[TBL] [Abstract][Full Text] [Related]
38. Prognosis and immunotherapy efficacy in dMMR&MSS colorectal cancer patients and an MSI status predicting model.
Fu X; Huang J; Zhu J; Fan X; Wang C; Deng W; Tan X; Chen Z; Cai Y; Lin H; Wang G; Zhang N; Zhu Y; Chen J; Zhan H; Huang S; Fang Y; Li Y; Huang Y
Int J Cancer; 2024 Aug; 155(4):766-775. PubMed ID: 38594805
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Study of Microsatellite Instability Testing and Its Comparison With Immunohistochemistry in Gastric Cancers.
Park Y; Nam SK; Seo SH; Park KU; Oh HJ; Park YS; Suh YS; Ahn SH; Park DJ; Kim HH; Lee HS
J Gastric Cancer; 2023 Apr; 23(2):264-274. PubMed ID: 37129151
[TBL] [Abstract][Full Text] [Related]
40. Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer.
Ukkola I; Nummela P; Pasanen A; Kero M; Lepistö A; Kytölä S; Bützow R; Ristimäki A
Virchows Arch; 2021 Sep; 479(3):471-479. PubMed ID: 33755781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
